Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Radboud University Nijmegen Medical Centre
Nimega, HolandaPublikationen in Zusammenarbeit mit Forschern von Radboud University Nijmegen Medical Centre (87)
2024
-
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA)
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 9, pp. 2706-2732
-
Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines
European Journal of Nuclear Medicine and Molecular Imaging
-
Report on palliative sedation medication usage: a survey of palliative care experts in Eight European countries
BMC Palliative Care, Vol. 23, Núm. 1
-
Revised European Association for Palliative Care (EAPC) recommended framework on palliative sedation: An international Delphi study
Palliative Medicine, Vol. 38, Núm. 2, pp. 213-228
-
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines
Breast, Vol. 78
-
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries
Heart and Lung, Vol. 68, pp. 131-144
2023
-
A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism
Thrombosis Update, Vol. 13
-
Blue Light Exposure: Ocular Hazards and Prevention—A Narrative Review
Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 755-788
-
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)
Leukemia
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
EJNMMI Radiopharmacy and Chemistry, Vol. 8, Núm. 1
-
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100
Gynecologic Oncology, Vol. 178, pp. 119-129
-
Monitoring the clinical practice of palliative sedation (PALSED) in patients with advanced cancer: an international, multicentre, non-experimental prospective observational study protocol
BMC Palliative Care, Vol. 22, Núm. 1
-
Regulations on palliative sedation: an international survey across eight European countries
European journal of public health, Vol. 33, Núm. 1, pp. 35-41
2022
-
Association of obesity with 3-month mortality in kidney failure patients with COVID-19
Clinical Kidney Journal, Vol. 15, Núm. 7, pp. 1348-1360
-
Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19
Transplantation, Vol. 106, Núm. 5, pp. 1012-1023
-
Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss
Otology and Neurotology, Vol. 43, Núm. 5, pp. 513-529
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1
-
Pregnancy in cystinosis patients with chronic kidney disease: A European case series
Journal of Inherited Metabolic Disease, Vol. 45, Núm. 5, pp. 963-968
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151